33 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Full Sequence Amino Acid Scanning of¿-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.
State University of New York
Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
University of Minnesota
Exploring the influence of the protein environment on metal-binding pharmacophores.
University of California
Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.
Panthera Biopharma
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
Microbiotix
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
University of California
Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy.
Panthera Biopharma
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
University of California
Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.
Panthera Biopharma
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.
National Institute of Allergy and Infectious Diseases
Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
Institute For Medical Research
Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.
Institute For Medical Research
5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.
Danylo Halytsky Lviv National Medical University
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.
Government College Women University
In-cell production of a genetically-encoded library based on the θ-defensin RTD-1 using a bacterial expression system.
University of Southern California
N2-(3,4-dimethylphenyl)-6-((4-(p-tolyl)piperazin-1-yl)methyl)-1,3,5-triazine-2,4-diamine
Glucox Biotech
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
Novartis
Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor.
University of Auckland